Cargando…
Treatment of electronic cigarette or vaping product use‐associated lung injury (EVALI) by corticosteroid and low‐dose pirfenidone: Report of a case
Electronic (e)‐cigarette or vaping product use‐associated lung injury (EVALI) is a novel and potentially lethal disease first reported in the United States. We report the case of a 56‐year‐old man who presented to our hospital with dyspnoea and cough lasting for 2 months after using an e‐cigarette f...
Autores principales: | Wu, Chia‐Hao, Liao, Ting‐Yu, Chen, Yung‐Hsuan, Kuo, Ping‐Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453260/ https://www.ncbi.nlm.nih.gov/pubmed/34584727 http://dx.doi.org/10.1002/rcr2.845 |
Ejemplares similares
-
E-CIGARETTE OR VAPING USE-ASSOCIATED LUNG INJURY (EVALI): EFFECTS OF VAPING OR COVID-19?
por: WALBRIDGE, GEORGE, et al.
Publicado: (2022) -
Suggested management of e-cigarette or vaping product use associated lung injury (EVALI)
por: Hage, René, et al.
Publicado: (2020) -
E-cigarette or Vaping Product Associated Lung Injury (EVALI) Presenting As Cardiac Arrest
por: Schekochikhina, Natalia, et al.
Publicado: (2022) -
CT features of electronic-cigarette or vaping-associated lung injury (EVALI); our experience during the recent outbreak
por: Girvin, Francis, et al.
Publicado: (2020) -
Chemical Constituents Involved in E-Cigarette, or Vaping Product Use-Associated Lung Injury (EVALI)
por: Muthumalage, Thivanka, et al.
Publicado: (2020)